title: [Thyroid cancer and its incidence in nodular thyroid diseases: our experience].
abstract: The authors report their experience with 453 cases of thyroid nodules observed over a period of 5 years. The intention was to determine the incidence of malignant lesions. A female prevalence of the nodular pathology was clearly evident (7.2%), with a maximum incidence between the 3rd and 6th decade. Among malignant tumors (14.2%) the following histologic types were most frequently found: papillary adenocarcinoma (5.7%), follicular adenocarcinoma (2.7%), occult cancer (2.7%), anaplastic cancer (2.3%). Up to the 4th decade female prevalence was clearly evident (Max in the 3rd decade; F/M ratio = 6.5); then an increased male incidence was registered bringing to a reduction of the F/M ratio (1.5 in the 5th and 6th decade) and to its inversion in the 7th decade (M/F = 1.25).
authors.affiliation: VI Patologia Speciale Chirurgica e Propedeutica Clinica, Università degli Studi La Sapienza, Roma.
authors.forename: F
authors.initials: F
authors.lastname: Stio
authors.forename: G
authors.initials: G
authors.lastname: Battisti
authors.forename: A
authors.initials: A
authors.lastname: Felici
authors.forename: P
authors.initials: P
authors.lastname: Franco
authors.forename: C
authors.initials: C
authors.lastname: Iavarone
authors.forename: M
authors.initials: M
authors.lastname: Marigliani
authors.forename: M
authors.initials: M
authors.lastname: Maceroni
authors.forename: A
authors.initials: A
authors.lastname: Brescia
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology*; D000231:Adenocarcinoma, Papillary / Q000453:epidemiology*; D000236:Adenoma / Q000453:epidemiology*; D000328:Adult; D000367:Age Factors; D000368:Aged; D002277:Carcinoma / Q000453:epidemiology*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007558:Italy; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D013959:Thyroid Diseases / Q000150:complications*; D013964:Thyroid Neoplasms / Q000453:epidemiology*
vernacular_title: Il cancro della tiroide e la sua incidenza nelle tireopatie nodulari: nostra esperienza.